Search Results - "Gupta, IV"

Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial by Hillmen, Peter, Prof, Robak, Tadeusz, MD, Janssens, Ann, MD, Babu, K Govind, MD, Kloczko, Janusz, MD, Grosicki, Sebastian, MD, Doubek, Michael, MD, Panagiotidis, Panagiotis, MD, Kimby, Eva, MD, Schuh, Anna, MD, Pettitt, Andrew R, MRCPath, Boyd, Thomas, MD, Montillo, Marco, MD, Gupta, Ira V, MD, Wright, Oliver, BSc, Dixon, Iestyn, BSc, Carey, Jodi L, RN BSN, Chang, Chai-Ni, MS, Lisby, Steen, MD, McKeown, Astrid, PhD, Offner, Fritz, MD

“…Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based…”
Get full text

Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study by Wierda, William G., Padmanabhan, Swaminathan, Chan, Geoffrey W., Gupta, Ira V., Lisby, Steen, Österborg, Anders

“…Ofatumumab, the human CD20 monoclonal antibody that binds a distinct epitope from rituximab, has demonstrated clinical benefit as monotherapy for patients with…”
Get full text

Ofatumumab retreatment and maintenance in fludarabine‐refractory chronic lymphocytic leukaemia patients by Österborg, Anders, Wierda, William G., Mayer, Jiří, Hess, Georg, Hillmen, Peter, Schetelig, Johannes, Schuh, Anna, Smolej, Lukáš, Beck, Christian, Dreyfus, Brigitte, Hellman, Andrzej, Kozlowski, Piotr, Pfreundschuh, Michael, Rizzi, Rita, Spacek, Martin, Phillips, Jennifer L., Gupta, Ira V., Williams, Vanessa, Jewell, Roxanne C., Nebot, Noelia, Lisby, Steen, Dyer, Martin J. S.

“…Summary There are limited data on retreatment with monoclonal antibodies (mAb) in patients with chronic lymphocytic leukaemia (CLL). In a pivotal study,…”
Get full text

A Clinical Case of Viral Keratitis by Gupta, Devanshu, Daigavane, Sachin

“…Keratitis is a pathological condition involving inflammation of the cornea. It can be an infectious or non-infectious disease. The causative organisms of…”
Get full text

PRETREATMENT CHARACTERISTICS CORRELATED WITH OUTCOMES IN PATIENTS WITH FLUDARABINE-REFRACTORY CLL TREATED WITH OFATUMUMAB: FINAL RESPONSE ANALYSIS by Wierda, WG, Gupta, IV, Lisby, S, Osterborg, A

Get full text

Final Analysis From the International Trial of Single-Agent Ofatumumab In Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia by Wierda, WG, Kipps, TJ, Mayer, J, Robak, T, Dyer, MJS, Eurman, RR, Hillmen, P, Stilgenbauer, S, Williams, CD, Trneny, M, Cartron, G, Hernandez-Ilizaliturri, FJ, Padmanabhan, S, Chan, GW, Gupta, IV, Gorczyca, MM, Davis, RL, Losic, N, Lisby, S, Osterborg, A

Get full text